NetworkNewsBreaks

TuesdayFeb 21, 2023 1:02 pm

NetworkNewsBreaks – Hempacco Co. Inc. (NASDAQ: HPCO) Closes on $7.245M Public Offering

Hempacco (NASDAQ: HPCO), a vertically integrated hemp manufacturing company, has closed on its upsized underwritten public offering. The offering consisted of an estimated 4,830,000 shares of common stock, including an additional 630,000 shares issued pursuant to the full exercise of the overallotment option by the underwriters. According to the announcement, the common shares were sold for $1.50 per share, resulting in gross proceeds of some $7.245 million before subtracting standard underwriting discounts, commissions and other offering expenses. The company anticipates using the offering’s net proceeds for sales and marketing along with potential acquisitions and upgrades to the company’s existing manufacturing facility,…

Continue Reading

TuesdayFeb 21, 2023 12:57 pm

NetworkNewsBreaks – First Northern Community Bancorp (FNRN) Reports Record-Year Performance in 2022

First Northern Community Bancorp (OTCQB: FNRN), holding company for First Northern Bank (“First Northern” or the “Bank”), today reported 2022 annual net income of $15.9 million, or $1.09 per diluted share. This reflected increases of 12% and 14.7%, respectively, when compared to net income of $14.2 million, or $.95 per diluted share, for 2021. In addition, net income for the quarter ended Dec. 31, 2022, totaled $4.7 million, or $.33 per diluted share, compared to net income of $3.2 million, or $.22 per diluted share, for the quarter ended Dec. 31, 2021. “We attribute our record-year performance to robust loan…

Continue Reading

TuesdayFeb 21, 2023 12:40 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Findings from Hypertension Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is reporting additional findings from its human clinical study HYPER-H21-4; the study is designed to demonstrate a potentially novel mechanism of action of LEXX’s patented DehydraTECH-processed cannabidiol ("CBD") capsule formulation in the treatment of blood pressure ("BP"). According to the announcement, Lexaria believes that those findings, which were published in the peer-reviewed “Biomedicine and Pharmacotherapy" journal, could support DehydraTECH-CBD qualification within existing Food and Drug Administration (“FDA”) guidelines. Previous results of the study indicated that primary efficacy and safety objectives were successfully achieved, including hypertensive patients seeing resting blood pressure…

Continue Reading

TuesdayFeb 21, 2023 12:29 pm

NetworkNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Announces Results of Annual Meeting of Stockholders

FingerMotion (NASDAQ: FNGR), a mobile data and services company, today announced the outcome of matters voted on at its recent annual meeting of stockholders, which took place on Feb. 17, 2023. Among the highlights, Hsien Loong Wong, Yew Poh Leong, Michael Chan and Eng Ho Ng were elected to the company’s board of directors, Centurion ZD CPA & Co. was appointed as FNGR’s independent registered public accounting firm, and the company’s 2023 Stock Incentive Plan, executive compensation and the amendment to the exercise price of outstanding stock options from $8.00 to $3.84 were approved. In addition, FingerMotion’s executive officers were…

Continue Reading

TuesdayFeb 21, 2023 11:36 am

NetworkNewsBreaks – SideChannel Inc. (SDCH) Announces Annual Meeting Results, Investor Day Highlights

SideChannel (OTCQB: SDCH), a provider of cybersecurity products and services to emerging, middle-market and enterprise companies, today announced the results of its annual meeting of stockholders and summarized highlights from its Investor Day broadcast, both of which occurred on Feb. 15, 2023. Results of the annual meeting included new board appointments, the ratified appointment of RBSM, LLP as the company’s independent auditor, and the granting of discretionary authority to the board of directors to combine outstanding shares of SideChannel’s common stock into a lesser number of outstanding shares, with the exact ratio to be determined by the board. During the…

Continue Reading

TuesdayFeb 21, 2023 11:31 am

NetworkNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Secures Multiple Contracts for Processing Organics at Sea to Sky Soils

EverGen (TSX.V: EVGN) (OTCQB: EVGIF) announced that its Sea to Sky Soils organic waste processing and composting facility has entered multiple contracts with a B.C. regional district for the processing of organic waste at the facility, which provides over 10,000 tonnes per annum. With a track record of operational excellence and sustainable practices, EverGen is one of the top regional processors of organics in B.C. The company’s commitment is to own and operate best-in-class facilities that offer its municipal and commercial partners both cost-effective and environmentally sustainable solutions for processing and recycling organics. “Contracts such as these de-risk our core…

Continue Reading

TuesdayFeb 21, 2023 11:16 am

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) to Interact with Leaders Pushing Boundaries of MS Research at Upcoming Forum

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders. The company today announced upcoming participation in the Americas Committee for Treatment and Research in Multiple Sclerosis (“ACTRIMS”) 2023 Forum taking place from Feb. 23-25 in San Diego, California, at the Marriott Marquis San Diego Marina. Founded in 1995, ACTRIMS is comprised exclusively of multiple sclerosis (“MS”) researchers and clinicians. “ACTRIMS provides us with an opportunity to interact with an esteemed community of leaders pushing the boundaries…

Continue Reading

TuesdayFeb 21, 2023 11:10 am

NetworkNewsBreaks – 121 Mining Investment Returns to Las Vegas on March 28-29, 2023

Building on the success of the inaugural 121 Mining Investment Las Vegas that was hosted last year, the upcoming two-day conference will facilitate the discovery of new mining projects, leverage unparalleled industry networks and enhance the investor education landscape. As the premier forum in the space, the event will focus on a series of thematic issues that are front and center to the mining industry, including energy transition, the gold outlook, precious metals investment strategies, uranium and the impacts of megatrends on metals and mining investing. For more information, visit https://www.weare121.com/121mininginvestment-las-vegas/ About 121 Group By hosting 121 Mining Investment events,…

Continue Reading

TuesdayFeb 21, 2023 10:57 am

NetworkNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Builds on Growing Success with Sales of New K1 Call Boxes

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, sees continued growth through sales of 11 K1 Call Boxes to Larimer County, Colorado. The transaction was completed through KSCP resale partner Stream Speed Technologies (“SST”). Knightscope’s smallest emergency call box system, the K1 Call Box, offers one-touch connection with a ruggedized housing and simple interface. The call box offers a completely wireless solution for emergency phone calls and can also work with existing nearby wiring nearby. In addition, the system includes additional options that allow people who are deaf, hard of hearing or…

Continue Reading

TuesdayFeb 21, 2023 10:40 am

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q2 2023 Financial, Corporate Report

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting on its second quarter of fiscal year 2023, the period that ended Dec. 31, 2022. Highlights of the report include the company closing the calendar year with nearly $11.5 million in cash and the completion of enrollment in the company’s phase 2 clinical trial in epidermolysis bullosa (“EB”). The report also noted that the company has seen advancement in its research using rare cannabinoids in the treatment of glaucoma and neurodegenerative diseases such as Alzheimer’s, Huntington’s and Parkinson’s. “This…

Continue Reading